• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2022 年基特森疟疾研讨会:从药物发现到治疗,对已取得的进展和未来的挑战进行了热烈讨论。

Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment.

机构信息

Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Laos.

出版信息

Trends Parasitol. 2022 Sep;38(9):711-718. doi: 10.1016/j.pt.2022.06.005. Epub 2022 Jul 18.

DOI:10.1016/j.pt.2022.06.005
PMID:35864072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9631389/
Abstract

In recent years, the field of malaria research has made substantial progress in the areas of antimalarial drug resistance and discovery. These efforts are essential to combatting the devastating impact of malaria, which, in 2020, resulted in an estimated 241 million cases and 627 000 deaths. Recent advances in this area were presented at a Keystone Symposium entitled ‘Malaria: Confronting Challenges from Drug Discovery to Treatment’, held in person in Breckenridge, Colorado, in April 2022. Herein, we present a summary of the proceedings of this vibrant scientific exchange, which brought together a superb group of faculty, postdocs, and students from around the globe.

摘要

近年来,疟疾研究领域在抗疟药物耐药性和发现方面取得了重大进展。这些努力对于抗击疟疾的毁灭性影响至关重要,2020 年疟疾估计导致 2.41 亿例病例和 62.7 万人死亡。在 2022 年 4 月于科罗拉多州布雷肯里奇以现场方式举行的主题为“疟疾:从药物发现到治疗应对挑战”的 Keystone 研讨会上介绍了该领域的最新进展。在此,我们总结了这次充满活力的科学交流会议的情况,来自全球的杰出教师、博士后和学生参加了这次会议。

相似文献

1
Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment.2022 年基特森疟疾研讨会:从药物发现到治疗,对已取得的进展和未来的挑战进行了热烈讨论。
Trends Parasitol. 2022 Sep;38(9):711-718. doi: 10.1016/j.pt.2022.06.005. Epub 2022 Jul 18.
2
Challenges facing drug development for malaria.疟疾药物研发面临的挑战。
Curr Opin Microbiol. 2008 Oct;11(5):428-33. doi: 10.1016/j.mib.2008.09.003. Epub 2008 Oct 14.
3
Supporting malaria elimination with 21st century antimalarial agent drug discovery.利用21世纪抗疟药物发现助力疟疾消除。
Drug Discov Today. 2015 Oct;20(10):1265-70. doi: 10.1016/j.drudis.2015.06.009. Epub 2015 Jun 21.
4
The global pipeline of new medicines for the control and elimination of malaria.全球控制和消除疟疾的新药研发管道。
Malar J. 2012 Sep 7;11:316. doi: 10.1186/1475-2875-11-316.
5
Discussion of contemporary malaria research needs as reflected in the symposium.研讨会上所反映的当代疟疾研究需求探讨。
Am J Trop Med Hyg. 1972 Sep;21(5):837-8. doi: 10.4269/ajtmh.1972.21.837.
6
Partnering to fight malaria in India: Past, present and future.携手抗击印度疟疾:过去、现在与未来
J Vector Borne Dis. 2019 Jan-Mar;56(1):15-24. doi: 10.4103/0972-9062.257769.
7
New developments in anti-malarial target candidate and product profiles.抗疟靶点候选物和产品概况的新进展。
Malar J. 2017 Jan 13;16(1):26. doi: 10.1186/s12936-016-1675-x.
8
Current therapies and future possibilities for drug development against liver-stage malaria.针对肝期疟疾的当前疗法及药物开发的未来可能性
J Clin Invest. 2016 Jun 1;126(6):2013-20. doi: 10.1172/JCI82981.
9
Efforts Made to Eliminate Drug-Resistant Malaria and Its Challenges.消除耐药性疟疾的努力及其面临的挑战。
Biomed Res Int. 2021 Aug 30;2021:5539544. doi: 10.1155/2021/5539544. eCollection 2021.
10
Recent advances in malaria drug discovery.疟疾药物发现的最新进展。
Bioorg Med Chem Lett. 2013 May 15;23(10):2829-43. doi: 10.1016/j.bmcl.2013.03.067. Epub 2013 Mar 27.

引用本文的文献

1
Defining the next generation of severe malaria treatment: a target product profile.定义下一代重症疟疾治疗方法:目标产品特征描述。
Malar J. 2024 Jun 5;23(1):174. doi: 10.1186/s12936-024-04986-z.

本文引用的文献

1
Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.低剂量磷酸萘酚喹在健康志愿者中对疟原虫感染的阻断活性实验。
Clin Infect Dis. 2023 Feb 8;76(3):506-512. doi: 10.1093/cid/ciac503.
2
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.酪氨酸 tRNA 合成酶的反应劫持作为一种新的全生命周期抗疟策略。
Science. 2022 Jun 3;376(6597):1074-1079. doi: 10.1126/science.abn0611. Epub 2022 Jun 2.
3
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.青蒿琥酯-咯萘啶联合阿莫地喹与青蒿琥酯-咯萘啶单药治疗耐青蒿素、无并发症恶性疟原虫疟疾的疗效比较:一项开放标签、随机、多中心试验。
Lancet Infect Dis. 2022 Jun;22(6):867-878. doi: 10.1016/S1473-3099(21)00692-7. Epub 2022 Mar 8.
4
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.新型三氨基嘧啶 ZY-19489 的安全性、药代动力学和抗疟活性:一项首次人体、随机、安慰剂对照、双盲、单次递增剂量研究、初步食物效应研究和志愿者感染研究。
Lancet Infect Dis. 2022 Jun;22(6):879-890. doi: 10.1016/S1473-3099(21)00679-4. Epub 2022 Mar 2.
5
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.INE963 的发现和临床前药理学研究:一种强效、速效的血期抗疟药,具有较高的抗药性屏障,有可能单剂治愈复杂疟疾。
J Med Chem. 2022 Mar 10;65(5):3798-3813. doi: 10.1021/acs.jmedchem.1c01995. Epub 2022 Mar 1.
6
Differential Incidence of Malaria in Neighboring Villages in a High-Transmission Setting of Southern Mali.马里南部高传播环境下相邻村庄疟疾的发病率差异
Am J Trop Med Hyg. 2022 Feb 28;106(4):1209-1214. doi: 10.4269/ajtmh.21-0788. Print 2022 Apr 6.
7
A Phenotypic Screen for the Liver Stages of .针对……肝期的表型筛选
Bio Protoc. 2021 Dec 5;11(23):e4253. doi: 10.21769/BioProtoc.4253.
8
Design of proteasome inhibitors with oral efficacy in vivo against and selectivity over the human proteasome.设计具有体内抗 和对人蛋白酶体选择性的口服功效的蛋白酶体抑制剂。
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39). doi: 10.1073/pnas.2107213118.
9
Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compounds.利用热蛋白质组分析来鉴定抗利什曼原虫化合物的分子靶点。
STAR Protoc. 2021 Aug 18;2(3):100704. doi: 10.1016/j.xpro.2021.100704. eCollection 2021 Sep 17.
10
Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention.化学生物基因组学鉴定乙酰辅酶 A 合成酶为疟疾治疗和预防的靶点。
Cell Chem Biol. 2022 Feb 17;29(2):191-201.e8. doi: 10.1016/j.chembiol.2021.07.010. Epub 2021 Aug 3.